Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,856 | -5,176 | -17,424 | -11,636 | -10,185 |
| Depreciation Amortization | 2 | 1 | 4 | 3 | 2 |
| Accounts payable and accrued liabilities | N/A | 552 | N/A | N/A | N/A |
| Other Working Capital | -2,854 | 109 | -1,984 | -2,641 | -2,463 |
| Other Operating Activity | 85 | -536 | 557 | 431 | 362 |
| Operating Cash Flow | $-13,623 | $-5,050 | $-18,847 | $-13,843 | $-12,284 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 12,367 | 12,367 | 14,293 | 13,176 | 1,994 |
| Financing Cash Flow | $12,367 | $12,367 | $14,293 | $13,176 | $1,994 |
| Exchange Rate Effect | 47 | 44 | -141 | 2 | 26 |
| Beginning Cash Position | 9,361 | 9,361 | 14,056 | 14,056 | 14,056 |
| End Cash Position | 8,151 | 16,723 | 9,361 | 13,391 | 3,792 |
| Net Cash Flow | $-1,210 | $7,361 | $-4,695 | $-665 | $-10,264 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,623 | -5,050 | -18,847 | -13,843 | -12,284 |
| Free Cash Flow | -13,623 | -5,050 | -18,847 | -13,843 | -12,284 |